Senior insider sale
TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$330.0K
10K shares
What this filing means
BAYNES ROY D. plans to sell 10K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $330.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/6/2026ACC: 0001950047-26-003230
10K
Shares to sell
$330.0K
Approx. market value
10K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
4/6/2026
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/6/2026 | Stock Option Exercise Cash | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
10K
Market value
$330.0K
4/6/2026
Total
Units
10K
Value
$330.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/6/2026 | 10K | $330.0K | NASDAQ | Planned |
| Total | 10K | $330.0K | ||